In an average-risk colorectal cancer screening population, a blood-based circulating tumor DNA test is feasible.

Pancreatic cancer (PC) remains one of the most lethal cancers worldwide, with only 13% of patients surviving more than five ...

Australians in their 30s and 40s are being diagnosed with cancer at unprecedented rates, with at least 10 types of the ...

Seven warning signs of pancreatic cancer you shouldn't ignore as these subtle symptoms often get dismissed but could save ...

Shares of Liminatus Pharma rose after the company shared plans to collaborate on developing a diagnostic kit for detecting pancreatic cancer. The stock advanced 3.7%, to $9.35, in after-hours trading ...

A 2022 study claims to have found that a certain blood type is linked to a higher risk of colorectal cancer. Colorectal ...

The Glasgow, Scotland-based firm's Panaromic Platform uses an infrared spectroscopy-based test with machine learning-developed algorithms to detect signals of cancer.

A similarly gloomy simulation posted by Dr Paulien Moyaert back in May documented how being diagnosed with cancer can lead to ...

MRI-based screening has the potential for identifying early-stage pancreatic cancer in older adults with new onset or deteriorating diabetes, preliminary results show.

FULLERTON, CA, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- Liminatus Pharma today announced that it has entered into a Memorandum of Understanding (MOU) to form a research and development ...

The QUILT-88 study reveals promising survival rates for advanced pancreatic cancer patients using a multimodal treatment ...

Imagine a routine blood donation quietly holding evidence of a future cancer diagnosis. A recent study published in Cancer ...